Table 2.
Second transplant characteristics.
| Characteristic | n | |
|---|---|---|
| Lines of re-induction therapy | ||
| none | 3 | |
| 1 | 18 | |
| 2 | 15 | |
| ≥3 | 4 | |
| Disease state pre-transplant | ||
| CR | 23 | |
| Responsive | 8 | |
| Refractory or PD | 9 | |
| Match of second donor | ||
| Haploidentical | 28 | |
| Full match | 10 | |
| Umbilical Cord | 2 | |
| Same donor first transplant | ||
| Yes | 4 | |
| No | 36 | |
| Conditioning regimens# | ||
| Flu/Cy/TBI | 27 | |
| Bu/Cy | 5 | |
| Cy/TBI | 3 | |
| Flu/Bu | 2 | |
| Flu/Mel | 1 | |
| Mel/TBI | 1 | |
| Bu/Cy/ATG | 1 | |
| GVHD prophylaxis | ||
| PTCy, MMF, Tacrolimus | 30 | |
| MTX/CSA | 4 | |
| Tacrolimus, MMF | 3 | |
| PTCy | 2 | |
| PTCy, CSA, MMF | 1 | |
PTCy – posttransplantation cyclophosphamide; MMF – mycophenolate mofetil.
#
For umbilical cord grafts (2 total), one patient received Bu/Cy conditioning, and one received Bu/Cy/ATG.